Biomarker analyses are becoming increasingly important in pre-clinical and clinical trials to understand the biological activity, safety, and efficacy profile of candidate therapeutics.

Somru BioScience has more than 70 methods available to our clients. We continue to add more methods to our list. Very often the development of bioanalytical methods for a novel biomarker is stalled due to lack of quality and specific reagents. Scientists at Somru have significant experience in not only developing robust bioanalytical assays for biomarkers but also have experience in generating quality reagents.